среда, 30 марта 2016 г.

FTC requests additional info from Pfizer and Allergan about pending merger

FTC requests additional info from Pfizer and Allergan about pending merger


The U.S. Federal Trade Commission has requested additional information from Pfizer and Allergan concerning their pending combination. It is a routine and entirely expected event.



from Biotech News